Costimulation, Coinhibition and Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|7|1|15-30

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.7, Iss.1, 2007-02, pp. : 15-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting T cell costimulation in autoimmune disease

By Racke Michael K   Stuart Rodney W  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 275-289

Informa Healthcare

Access to resources Recommend Favorite

Modulation of T-Cell Co-Stimulation in Rheumatoid Arthritis: Clinical Experience with Abatacept

By Laganà Bruno   Vinciguerra Marta   D'Amelio Raffaele  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 185-202

Adis International

Access to resources Recommend Favorite

Co-Stimulation Blockade as a New Strategy in Kidney Transplantation: Benefits and Limits

By Snanoudj Renaud   Zuber Julien   Legendre Christophe  

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2121-2131

Adis International

Access to resources Recommend Favorite

Therapeutic Blockade of TCR Signal Transduction and Co-Stimulation in Autoimmune Disease

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ASP2408, a Potent Selective T‐Cell Costimulation Modulator After Single and Multiple Ascending Doses in Healthy Volunteers and RA Patients

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 5, 2016-09 ,pp. : 408-425

John Wiley & Sons Inc

Access to resources Recommend Favorite